Coronary artery disease (CAD) is a significant contributor to global health burden. Adiponectin gene single nucleotide polymorphisms (SNPs) have been associated with CAD susceptibility, but with inconsistent results across the studies. We present, in this study, an updated meta-analysis to discern the genetic susceptibility of adiponectin SNPs in relation to CAD. PubMed and EMBASE databases were used to identify the relevant published articles using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Pooled odds ratios and 95% confidence intervals were generated to assess the strength of the associations. Thirty-five articles with a total of 28,947 participants (mean age 55.3 years, 11,632 cases/17,315 controls, 19,443 males/8353 females, and 1151 persons with unspecified gender data) were included. The dominant, recessive, and additive models were applied. We found that the SNPs +45T>G (rs2241766), −4034A>C (rs822395), and −11391G>A (rs17300539) were linked to CAD development. In addition, +276G>T (rs1501299) SNP was associated with a decreased susceptibility to CAD among Caucasians. We did not find an association between the CAD susceptibility and the −11377C>G (rs266729) SNP. These observations offer new potential genetic biomarker candidates in relation to CAD, and warrant further research in independent world populations.
Get full access to this article
View all access options for this article.
References
1.
Al-DaghriNM, Al-AttasOS, AlokailMS, AlkharfyKM, and HussainT. (2011). Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes. Mol Biol Rep, 38, 3703–3708.
2.
AmehOI, OkpechiIG, DandaraC, and KengneAP. (2017). Association between telomere length, chronic kidney disease, and renal traits. A Systematic Review. OMICS, 21, 143–155.
3.
AntonopoulosAS, TousoulisD, AntoniadesC, et al. (2013). Genetic variability on adiponectin gene affects myocardial infarction risk: The role of endothelial dysfunction. Int J Cardiol, 168, 326–330.
4.
BacciS, MenzaghiC, ErcolinoT, et al. (2004). The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care, 27, 2015–2020.
5.
BoumaizaI, OmezzineA, RejebJ, et al. (2011). Single-nucleotide polymorphisms at the adiponectin locus and risk of coronary artery disease in Tunisian coronaries. J Cardiovasc Med (Hagerstown), 12, 619–624.
6.
ChangYC, JiangJY, JiangYD, et al. (2009). Interaction of ADIPOQ gene polymorphisms with blood pressure and plasma cholesterol level on the risk of coronary artery disease. Circ J, 73, 1934–1938.
7.
CheungCY, HuiEY, CheungBM, et al. (2014). Adiponectin gene variants and the risk of coronary heart disease: A 16 year longitudinal study. Eur J Endocrinol, 171, 107–115.
8.
ChiodiniBD, SpecchiaC, GoriF, et al. (2010). Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: An association study in an Italian population. Ther Adv Cardiovasc Dis, 4, 223–230.
9.
De CaterinaR, TalmudPJ, MerliniPA, et al. (2011). Strong association of the APOA5 − 1131T>C gene variant and early-onset acute myocardial infarction. Atherosclerosis, 214, 397–403.
10.
DuSX, LuLL, LiuY, DongQJ, XuanSY, and XinYN. (2016). Association of adiponectin gene polymorphisms with the risk of coronary artery disease in patients with nonalcoholic fatty liver disease in a Chinese Han population. Hepat Mon, 16, e37388.
11.
EsteghamatiA, MansourniaN, NakhjavaniM, MansourniaMA, NikzamirA, and AbbasiM. (2012). Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes. Mol Biol Rep, 39, 3791–3797.
12.
FilippiE, SentinelliF, RomeoS, et al. (2005). The adiponectin gene SNP +276G> T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age <or = 50 years). J Mol Med (Berl), 83, 711–719.
13.
FoucanL, EzourhiN, MaimaitimingS, et al. (2010). Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent. Obesity (Silver Spring), 18, 1466–1468.
14.
FranckeS, ManrajM, LacquemantC, et al. (2001). A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet, 10, 2751–2765.
15.
FumeronF, AubertR, SiddiqA, et al. (2004). Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: The epidemiologic data on the insulin resistance syndrome prospective study. Diabetes, 53, 1150–1157.
16.
GableDR, MatinJ, WhittallR, et al. (2007). Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann Hum Genet, 71, 453–466.
17.
GnacińskaM, MałgorzewiczS, StojekM, Łysiak-SzydłowskaW, and SworczakK. (2009). Role of adipokines in complications related to obesity: A review. Adv Med Sci, 54, 150–157.
18.
GuiMH, LiX, JiangSF, GaoJ, LuDR, and GaoX. (2012). Association of the adiponectin gene rs1501299 G<T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population. Diabetes Res Clin Pract, 97, 499–504.
19.
HegenerHH, LeeIM, CookNR, RidkerPM, and ZeeRY. (2006). Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: A nested case-control study. Clin Chem, 52, 2021–2027.
20.
HoefleG, MuendleinA, SaelyCH, et al. (2007). The −11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men. Thromb Haemost, 97, 451–457.
21.
JangY, LeeJH, ChaeJS, et al. (2005). Association of the 276G->T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr, 82, 760–767.
22.
JungCH, RheeEJ, KimSY, et al. (2006). Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases. Endocr J, 53, 671–677.
23.
KaradumanM, SengulA, OktenliC, et al. (2006). Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin Endocrinol (Oxf), 64, 196–202.
24.
KatakamiN, KanetoH, MatsuokaTA, et al. (2012). Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes. Atherosclerosis, 220, 437–442.
25.
LacquemantC, FroguelP, LobbensS, IzzoP, DinaC, and RuizJ. (2004). The adiponectin gene SNP +45 is associated with coronary artery disease in type 2 (non-insulindependent) diabetes mellitus. Diabet Med, 21, 776–781.
26.
MackawyAM. (2013). Association of +45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women. Gene, 530, 158–163.
27.
MenzaghiC, ErcolinoT, PaolaRD, et al. (2002). A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes, 51, 2306–2312.
28.
MofarrahM, ZiaeeS, Pilehvar-SoltanahmadiY, ZarghamiF, BoroumandM, and ZarghamiN. (2016). Association of KALRN, ADIPOQ, and FTO gene polymorphism in type 2 diabetic patients with coronary artery disease: Possible predisposing markers. Coron Artery Dis, 27, 490–496.
29.
MohammadzadehG, GhaffariMA, HeibarH, and BazyarM. (2016). Association of two common single nucleotide polymorphisms (+45T/G and +276G/T) of ADIPOQ gene with coronary artery disease in type 2 diabetic patients. Iran Biomed J, 20, 152–160.
30.
NakanoY, TobeT, Choi-MiuraNH, MazdaT, and TomitaM. (1996). Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem, 120, 803–812.
31.
OguriM, KatoK, YokoiK, et al. (2009). Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. Atherosclerosis, 206, 486–493.
32.
OhashiK, OuchiN, KiharaS, et al. (2004). Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol, 43, 1195–1200.
33.
OliveiraCS, Saddi-RosaP, CrispimF, et al. (2012). Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. J Diabetes Complications, 26, 94–98.
34.
OuchiN, KobayashiH, KiharaS, et al. (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. Biol Chem, 279, 1304–1309.
35.
ParkJW, ParkJ, and JeeSH. (2011). ADIPOQ gene variants associated with susceptibility to obesity and low serum adiponectin levels in healthy Koreans. Epidemiol Health, 33, e2011003.
36.
PerssonJ, LindbergK, GustafssonTP, ErikssonP, Paulsson-BerneG, and LundmanP. (2010). Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med, 268, 194–205.
37.
PischonT, PaiJK, MansonJE, et al. (2007). Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. Obesity (Silver Spring), 15, 2051–2060.
38.
PriorSL, GableDR, CooperJA, et al. (2009). Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus. Eur Heart J, 30, 1263–1269.
39.
PriorSL, JonesDA, GillGV, et al. (2011). Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk ‘Golden Years’ type 1 diabetes cohort. Diabetes Res Clin Pract, 91, e71–e74.
40.
QiL, LiT, RimmE, et al. (2005). The +276 polymorphism of the APM1 gene plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes, 54, 1607–1610.
41.
RichardsJB, WaterworthD, O'RahillyS, et al. (2009). A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet, 5, 1000768.
42.
RizkNM, El-MenyarA, MareiI, et al. (2012). Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology, 64, 257–265.
43.
Rodriguez-RodriguezL, Garcia-BermudezM, Gonzalez-JuanateyC, et al. (2011). Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. Tissue Antigens, 77, 74–78.
44.
SabouriS, Ghayour-MobarhanM, MoohebatiM, et al. (2011). Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population. ScientificWorldJournal, 11, 93–101.
45.
ShenD, XingS, and ChenC. (2015). Adiponectin gene polymorphisms contributes to ischemic stroke risk: A meta-analysis. J Renin Angiotensin Aldosterone Syst, 16, 178–184.
46.
SunK, LiY, WeiC, TongY, ZhengH, and GuoY. (2012). Recessive protective effect of ADIPOQ rs1501299 on cardiovascular diseases with type 2 diabetes: A meta-analysis. Mol Cell Endocrinol, 349, 162–169.
47.
ThakkinstianA, McEvoyM, MinelliC, et al. (2005). Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: A HuGE review. Am J Epidemiol, 162, 201–211.
48.
VaiopoulosAG, MarinouK, ChristodoulidesC, and KoutsilierisM. (2012). The role of adiponectin in human vascular physiology. Int J Cardiol, 155, 188–193.
49.
VedanthanR, SeligmanB, and FusterV. (2014). Global perspective on acute coronary syndrome: A burden on the young and poor. Circ Res, 114, 1959–1975.
50.
WasselCL, PankowJS, Rasmussen-TorvikLJ, et al. (2011). Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA). Obesity (Silver Spring), 19, 840–847.
51.
YangY, ZhangF, DingR, WangY, LeiH, and HuD. (2012). Association of ADIPOQ gene polymorphisms and coronary artery disease risk: A meta-analysis based on 12465 subjects. Thromb Res, 130, 58–64.
52.
ZhangBC, LiWM, and XuYW. (2012). A meta-analysis of the association of adiponectin gene polymorphisms with coronary heart disease in Chinese Han population. Clin Endocrinol (Oxf), 76, 358–364.
53.
ZhangH, MoX, HaoY, and GuD. (2012). Association between polymorphisms in the adiponectin gene and cardiovascular disease: A meta-analysis. BMC Med Genet, 28, 13–40.
54.
ZhangL, DaiY, BianL, et al. (2011). Association of the cell death-inducing DNA fragmentation factor alpha-like effector A (CIDEA) gene V115F (G/T) polymorphism with phenotypes of metabolic syndrome in a Chinese population. Diabetes Res Clin Pract, 91, 233–238.
55.
ZhangM, PengY, and LyuSZ. (2016). Association between genetic variants in the adiponectin gene and premature myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi, 44, 577–582.
56.
ZhaoF, MamatyusupuD, WangY, et al. (2016). The Uyghur population and genetic susceptibility to type 2 diabetes: Potential role for variants in CAPN10, APM1 and FUT6 genes. J Cell Mol Med, 20, 2138–2147.
57.
ZhongC, ZhenD, QiQ, and GenshanM. (2010). A lack of association between adiponectin polymorphisms and coronary artery disease in a Chinese population. Genet Mol Biol, 33, 428–433.
58.
ZhouD, JinY, YaoF, DuanZ, WangQ, and LiuJ. (2014). Association between the adiponectin +45T>G genotype and risk of cardiovascular disease: A meta-analysis. Heart Lung Circ, 23, 159–165.
59.
ZhouL, XiB, WeiY, et al. (2012). Association between adiponectin gene polymorphisms and coronary artery disease across different populations. Thromb Res, 130, 52–57.
60.
ZhouNN, ZhuoJM, WangJC, LiXD, and YeL. (2011). Correlation of adiponectin gene SNP +45T/G polymorphism and premature coronary heart disease of Han ethnic males. Zhonghua Yi Xue Za Zhi, 91, 3413–3416.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
